In Brief: House Medicare bill
This article was originally published in The Tan Sheet
Executive Summary
House Medicare bill: HR 2425 is approved by a 231-201 vote on Oct. 19 after one day of floor debate. The measure contains a provision that would prohibit the award of punitive damages against a drug or medical device manufacturer if the product was approved by FDA. The Justice Department wrote House Ways & Means Committee Chairman Bill Archer (R-Tex.) on Oct. 12, arguing that the section of the bill related to medical liability reform "represent[s] an unacceptable extension of federal authority over an area of the law historically left to the states" and "is totally inappropriate to the budget reconciliation process." The Senate Medicaid/Medicare package, which does not contain the medical liability provision, is expected to be considered on the floor late in the week of Oct. 23...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning